Cargando…

Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury

Tissue loss after spinal trauma is biphasic, with initial mechanical/haemorrhagic damage at the time of impact being followed by gradual secondary expansion into adjacent, previously unaffected tissue. Limiting the extent of this secondary expansion of tissue damage has the potential to preserve gre...

Descripción completa

Detalles Bibliográficos
Autores principales: Koehn, Liam M., Noor, Natassya M., Dong, Qing, Er, Sing-Yan, Rash, Lachlan D., King, Glenn F., Dziegielewska, Katarzyna M., Saunders, Norman R., Habgood, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200949/
https://www.ncbi.nlm.nih.gov/pubmed/28105306
http://dx.doi.org/10.12688/f1000research.9094.2
_version_ 1782489272444518400
author Koehn, Liam M.
Noor, Natassya M.
Dong, Qing
Er, Sing-Yan
Rash, Lachlan D.
King, Glenn F.
Dziegielewska, Katarzyna M.
Saunders, Norman R.
Habgood, Mark D.
author_facet Koehn, Liam M.
Noor, Natassya M.
Dong, Qing
Er, Sing-Yan
Rash, Lachlan D.
King, Glenn F.
Dziegielewska, Katarzyna M.
Saunders, Norman R.
Habgood, Mark D.
author_sort Koehn, Liam M.
collection PubMed
description Tissue loss after spinal trauma is biphasic, with initial mechanical/haemorrhagic damage at the time of impact being followed by gradual secondary expansion into adjacent, previously unaffected tissue. Limiting the extent of this secondary expansion of tissue damage has the potential to preserve greater residual spinal cord function in patients. The acute tissue hypoxia resulting from spinal cord injury (SCI) activates acid-sensing ion channel 1a (ASIC1a). We surmised that antagonism of this channel should provide neuroprotection and functional preservation after SCI. We show that systemic administration of the spider-venom peptide PcTx1, a selective inhibitor of ASIC1a, improves locomotor function in adult Sprague Dawley rats after thoracic SCI. The degree of functional improvement correlated with the degree of tissue preservation in descending white matter tracts involved in hind limb locomotor function. Transcriptomic analysis suggests that PcTx1-induced preservation of spinal cord tissue does not result from a reduction in apoptosis, with no evidence of down-regulation of key genes involved in either the intrinsic or extrinsic apoptotic pathways. We also demonstrate that trauma-induced disruption of blood-spinal cord barrier function persists for at least 4 days post-injury for compounds up to 10 kDa in size, whereas barrier function is restored for larger molecules within a few hours. This temporary loss of barrier function provides a “ treatment window” through which systemically administered drugs have unrestricted access to spinal tissue in and around the sites of trauma. Taken together, our data provide evidence to support the use of ASIC1a inhibitors as a therapeutic treatment for SCI. This study also emphasizes the importance of objectively grading the functional severity of initial injuries (even when using standardized impacts) and we describe a simple scoring system based on hind limb function that could be adopted in future studies.
format Online
Article
Text
id pubmed-5200949
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-52009492017-01-18 Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury Koehn, Liam M. Noor, Natassya M. Dong, Qing Er, Sing-Yan Rash, Lachlan D. King, Glenn F. Dziegielewska, Katarzyna M. Saunders, Norman R. Habgood, Mark D. F1000Res Research Article Tissue loss after spinal trauma is biphasic, with initial mechanical/haemorrhagic damage at the time of impact being followed by gradual secondary expansion into adjacent, previously unaffected tissue. Limiting the extent of this secondary expansion of tissue damage has the potential to preserve greater residual spinal cord function in patients. The acute tissue hypoxia resulting from spinal cord injury (SCI) activates acid-sensing ion channel 1a (ASIC1a). We surmised that antagonism of this channel should provide neuroprotection and functional preservation after SCI. We show that systemic administration of the spider-venom peptide PcTx1, a selective inhibitor of ASIC1a, improves locomotor function in adult Sprague Dawley rats after thoracic SCI. The degree of functional improvement correlated with the degree of tissue preservation in descending white matter tracts involved in hind limb locomotor function. Transcriptomic analysis suggests that PcTx1-induced preservation of spinal cord tissue does not result from a reduction in apoptosis, with no evidence of down-regulation of key genes involved in either the intrinsic or extrinsic apoptotic pathways. We also demonstrate that trauma-induced disruption of blood-spinal cord barrier function persists for at least 4 days post-injury for compounds up to 10 kDa in size, whereas barrier function is restored for larger molecules within a few hours. This temporary loss of barrier function provides a “ treatment window” through which systemically administered drugs have unrestricted access to spinal tissue in and around the sites of trauma. Taken together, our data provide evidence to support the use of ASIC1a inhibitors as a therapeutic treatment for SCI. This study also emphasizes the importance of objectively grading the functional severity of initial injuries (even when using standardized impacts) and we describe a simple scoring system based on hind limb function that could be adopted in future studies. F1000Research 2016-12-07 /pmc/articles/PMC5200949/ /pubmed/28105306 http://dx.doi.org/10.12688/f1000research.9094.2 Text en Copyright: © 2016 Koehn LM et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Koehn, Liam M.
Noor, Natassya M.
Dong, Qing
Er, Sing-Yan
Rash, Lachlan D.
King, Glenn F.
Dziegielewska, Katarzyna M.
Saunders, Norman R.
Habgood, Mark D.
Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title_full Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title_fullStr Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title_full_unstemmed Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title_short Selective inhibition of ASIC1a confers functional and morphological neuroprotection following traumatic spinal cord injury
title_sort selective inhibition of asic1a confers functional and morphological neuroprotection following traumatic spinal cord injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200949/
https://www.ncbi.nlm.nih.gov/pubmed/28105306
http://dx.doi.org/10.12688/f1000research.9094.2
work_keys_str_mv AT koehnliamm selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT noornatassyam selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT dongqing selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT ersingyan selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT rashlachland selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT kingglennf selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT dziegielewskakatarzynam selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT saundersnormanr selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury
AT habgoodmarkd selectiveinhibitionofasic1aconfersfunctionalandmorphologicalneuroprotectionfollowingtraumaticspinalcordinjury